98 related articles for article (PubMed ID: 7507589)
21. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
22. Phenylpropanolamine pharmacokinetics in dogs after intravenous, oral, and oral controlled-release doses.
Hussain MA; Aungst BJ; Lam G; Shefter E
Biopharm Drug Dispos; 1987; 8(5):497-505. PubMed ID: 3663885
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
[TBL] [Abstract][Full Text] [Related]
24. Use of oral decongestants during pregnancy and delivery outcome.
Källén BA; Olausson PO
Am J Obstet Gynecol; 2006 Feb; 194(2):480-5. PubMed ID: 16458650
[TBL] [Abstract][Full Text] [Related]
25. Metabolites of ephedrines in human urine after administration of a single therapeutic dose.
Tseng YL; Shieh MH; Kuo FH
Forensic Sci Int; 2006 Mar; 157(2-3):149-55. PubMed ID: 15885945
[TBL] [Abstract][Full Text] [Related]
26. Phenylpropanolamine's decongestive effect on the nasalmucosa of pregnant women with nasal stuffiness.
Toll K; Graf P
Rhinology; 2006 Dec; 44(4):274-7. PubMed ID: 17216745
[TBL] [Abstract][Full Text] [Related]
27. Steady state pharmacokinetics and dose-proportionality of phenylpropanolamine in healthy subjects.
Scherzinger SS; Dowse R; Kanfer I
J Clin Pharmacol; 1990 Apr; 30(4):372-7. PubMed ID: 2341583
[TBL] [Abstract][Full Text] [Related]
28. The glycemic effects of sympathomimetics in stressed mice.
Fletcher HP; Wannarka GL; Sandage BW
Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):377-88. PubMed ID: 7043680
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of pseudoephedrine in rats, dogs, monkeys and its pharmacokinetic-pharmacodynamic relationship in a feline model of nasal congestion.
Palamanda JR; Mei H; Morrison R; McLeod RL; McCormick K; Corboz M; Xu X; Korfmacher W; Broske L; Nomeir AA
Drug Metab Lett; 2010 Apr; 4(2):56-61. PubMed ID: 20446910
[TBL] [Abstract][Full Text] [Related]
30. The pharmacology of alpha-adrenergic decongestants.
Johnson DA; Hricik JG
Pharmacotherapy; 1993; 13(6 Pt 2):110S-115S; discussion 143S-146S. PubMed ID: 7507588
[TBL] [Abstract][Full Text] [Related]
31. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine.
Bende M; Andersson KE; Johansson CJ; Sjögren C; Svensson G
Acta Otolaryngol; 1984; 98(5-6):543-7. PubMed ID: 6084394
[TBL] [Abstract][Full Text] [Related]
32. The phenylephrine concentration-response relationship for blood pressure after nasal delivery in children.
Anderson BJ; Christensen LK; Armstead VE; Bilyeu DP; Johnson KE; Friesen RH
Paediatr Anaesth; 2017 Oct; 27(10):1050-1055. PubMed ID: 28868789
[TBL] [Abstract][Full Text] [Related]
33. An open-label, randomized, four-treatment crossover study evaluating the effects of salt form, acetaminophen, and food on the pharmacokinetics of phenylephrine.
Gelotte CK
Regul Toxicol Pharmacol; 2018 Jun; 95():333-338. PubMed ID: 29635061
[TBL] [Abstract][Full Text] [Related]
34. Time dependent pharmacokinetic interaction between phenylpropanolamine and chlorpheniramine maleate in human subjects.
Rao VV; Rambhau D; Rao BR; Srinivasu P
Drug Metabol Drug Interact; 1999; 15(4):259-68. PubMed ID: 10716040
[TBL] [Abstract][Full Text] [Related]
35. Direct detection of phenylephrine 3-O-sulfate in LS180 human intestinal cells using a novel hydrophilic interaction liquid chromatography (HILIC) assay.
Shah HN; Halquist MT; Gerk PM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():67-72. PubMed ID: 27912158
[TBL] [Abstract][Full Text] [Related]
36. Influences of urinary pH on the pharmacokinetics of three amphetamine-type stimulants using a new high-performance liquid chromatographic method.
Wang L; Feng F; Wang XQ; Zhu L
J Pharm Sci; 2009 Feb; 98(2):728-38. PubMed ID: 18481797
[TBL] [Abstract][Full Text] [Related]
37. Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control.
Chester N; Mottram DR; Reilly T; Powell M
Br J Clin Pharmacol; 2004 Jan; 57(1):62-7. PubMed ID: 14678341
[TBL] [Abstract][Full Text] [Related]
38. Preparation of phenylephrine 3-O-sulfate as the major in vivo metabolite of phenylephrine to facilitate its pharmacokinetic and metabolism studies.
Zhang Z; Zhang Y; Gerk PM
J Pharmacol Toxicol Methods; 2019; 95():66-69. PubMed ID: 30502391
[TBL] [Abstract][Full Text] [Related]
39. Effects of generally recognized as safe (GRAS) and dietary compounds on phenylephrine metabolism in LS180 human intestinal cells.
Zhang Z; Gerk PM
Biopharm Drug Dispos; 2018 Nov; 39(9):443-447. PubMed ID: 30368855
[TBL] [Abstract][Full Text] [Related]
40. Non-prescription sympathomimetic agents and hypertension.
Chua SS; Benrimoj SI
Med Toxicol Adverse Drug Exp; 1988; 3(5):387-417. PubMed ID: 3057328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
